Immediate Impact
68 standout
Citing Papers
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Colorectal cancer
2024 Standout
Works of Ferrán Losa being referenced
LBA16 Primary analysis of efficacy and safety in the CUPISCO trial: A randomised, global study of targeted therapy or cancer immunotherapy guided by comprehensive genomic profiling (CGP) vs platinum-based chemotherapy (CTX) in newly diagnosed, unfavourable cancer of unknown primary (CUP)
2023
Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ferrán Losa | 905 | 345 | 291 | 68 | 1.1k | |
| Marco Massani | 465 | 546 | 249 | 51 | 1.0k | |
| Kanwal Raghav | 554 | 357 | 341 | 51 | 1.1k | |
| Nathalie Guedj | 512 | 481 | 205 | 50 | 1.3k | |
| Silvia Mezi | 983 | 231 | 398 | 50 | 1.3k | |
| Marcos V. Perini | 456 | 549 | 316 | 94 | 1.1k | |
| U Laffer | 814 | 477 | 198 | 63 | 1.2k | |
| Christian Cotsoglou | 400 | 459 | 230 | 44 | 860 | |
| Alvin L. Watne | 395 | 323 | 386 | 64 | 1.0k | |
| Toshiki Masuishi | 649 | 183 | 395 | 156 | 993 | |
| Paolo Aurello | 627 | 730 | 626 | 102 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...